Posted on 25th November 2014
Popular in the US, Avastin is used for patients with age-related macular degeneration (AMD). It has been on the market for years, gone through all the testing and has been proven to be as effective as Lucentis, the NHS approved drug for the same condition. The difference is cost. Lucentis typically costs around £700 per treatment, compared to Avastin which is about £70. Yet red tape seems to be halting its use.
It is currently unlicensed in the UK so should anything go wrong with its use, the practitioner may not be legally covered. However, in times of austerity and it is perhaps time for the NHS to move forward and license its use.
21st March 2019
This year marks 25 years with the practice for Lesley Kerr and Heather Grandon. The loyal and dependable duo have been at the heart of the practice for a quarter century, a period when the practice ha...Read more
27th February 2019
We are delighted to welcome Hemp Eyewear to the Frame Room this month. Proudly unconventional: the materials, the process, the design and the look. This is such an exciting brand on so many levels. ...Read more
19th February 2019
Heather Muir and Heather Grandon headed south to Hemel Hempstead to Cantor & Nissel, the company we use to manufacturer cosmetic lenses for our patients. We have used the company for many years, c...Read more